AZN AstraZeneca PLC
$170.99▼ -0.62%
Healthcare
Other
Volume 373.1K
Avg Volume (10D) 3.29M
Key Metrics & Fundamentals
Market Cap
$265.19B
P/E Ratio
25.5
Div Yield
1.86%
52W Range
153.41 - 212.71
% vs 50 MA
5.30%
% vs 200 MA
-4.65%
RSI-14
63.3
MACD Histogram
+1.4200
Beta (1Y vs SPY)
0.23
Free Cash Flow
-$240.00M
Gross Rev
$15.38B
Gross Profit
$12.86B
EBITDA
$5.16B
COGS
$2.52B
Operating Exp
$9.70B
Operating Income
$3.16B
EBIT
$3.16B
Pretax Income
$2.80B
Net Income
$2.51B
EPS (Diluted)
1.61
Price & Volume History
Loading chart…
Recent News
Is Merck Stock a Buy, Sell or Hold Ahead of Q3 Earnings?
Zacks · Oct 27, 2026 7:56 AM ET
AstraZeneca, Daiichi Sankyo's Enhertu Wins EU Approval in Early Breast Cancer
MT Newswires · Oct 27, 2026 4:58 AM ET
Enhertu® Approved in the EU as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer
Business Wire · Oct 27, 2026 3:30 AM ET
Innate Pharma: PACIFIC-9 Phase 3 Trial Readout Timing Updated to H1 2027
Business Wire · Oct 27, 2026 2:00 AM ET
AstraZeneca Highlights Breakthrough Cancer Data at ESMO 2026 Investor Update
MarketBeat · Oct 26, 2026 9:02 PM ET
Onco360® Has Been Selected as a National Pharmacy Partner for ZEGFROVY® (sunvozertinib)
GlobeNewswire · Oct 26, 2026 5:00 PM ET
Moderna’s Cancer Vaccine Rally Hits a Wall. This Other Drugmaker Stole the Show.
Barrons.com · Oct 26, 2026 4:21 PM ET
AstraZeneca (LSE:AZN) Posted Positive Phase III Results For Three Cancer Drugs
Simply Wall St. · Oct 26, 2026 1:15 PM ET
European Stocks Close Higher in Monday Trading as Oil Prices Ease, Bond Yields Stabilize
MT Newswires · Oct 26, 2026 12:07 PM ET
Concurrence Appoints Dr. Hythem Sidky, Former Lead of the NIH National Clinical Cohort Collaborative, as Head of Applied AI
PR Newswire · Oct 26, 2026 10:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See AZN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.